PortfoliosLab logoPortfoliosLab logo
LENZ vs. OXLC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

LENZ vs. OXLC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in LENZ Therapeutics Inc (LENZ) and Oxford Lane Capital Corp. (OXLC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LENZ achieves a -66.88% return, which is significantly lower than OXLC's -2.62% return.


LENZ

1D
-7.99%
1M
-10.02%
6M
-66.50%
YTD
-66.88%
1Y
-82.31%
3Y*
-14.10%
5Y*
-40.52%
10Y*
ALL TIME*
-40.32%

OXLC

1D
2.12%
1M
6.34%
6M
14.48%
YTD
-2.62%
1Y
-6.01%
3Y*
-3.45%
5Y*
-1.74%
10Y*
5.56%
ALL TIME*
4.39%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$4.68M$5.83M$5.89M
$8.22M$7.92M$9.50M

LENZ vs. OXLC - Yearly Performance Comparison


2026 (YTD)20252024202320222021
LENZ
LENZ Therapeutics Inc
-66.88%-44.58%230.71%-21.08%-73.29%-43.76%
OXLC
Oxford Lane Capital Corp.
-2.62%-24.38%24.58%16.52%-24.15%9.98%

Correlation

The correlation between LENZ and OXLC is 0.04, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.04

Correlation (3Y)
Balances recent behavior with more history.

0.10

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.13

Correlation (All Time)
Calculated using the full available price history since Jun 25, 2021

0.13

Fundamentals

Market Cap

LENZ:

$166.18M

OXLC:

$894.02M

EPS

LENZ:

-$3.59

OXLC:

-$5.82

PS Ratio

LENZ:

7.66

OXLC:

0.99

PB Ratio

LENZ:

0.67

OXLC:

0.86

Total Revenue (TTM)

LENZ:

$20.99M

OXLC:

$849.13M

Gross Profit (TTM)

LENZ:

$19.37M

OXLC:

$793.40M

EBITDA (TTM)

LENZ:

-$116.01M

OXLC:

-$578.64M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LENZ vs. OXLC — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

LENZ
LENZ Risk / Return Rank: 66
Overall Rank
LENZ Sharpe Ratio Rank: 44
Sharpe Ratio Rank
LENZ Sortino Ratio Rank: 22
Sortino Ratio Rank
LENZ Omega Ratio Rank: 33
Omega Ratio Rank
LENZ Calmar Ratio Rank: 77
Calmar Ratio Rank
LENZ Martin Ratio Rank: 1212
Martin Ratio Rank

OXLC
OXLC Risk / Return Rank: 3636
Overall Rank
OXLC Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
OXLC Sortino Ratio Rank: 3333
Sortino Ratio Rank
OXLC Omega Ratio Rank: 3333
Omega Ratio Rank
OXLC Calmar Ratio Rank: 3939
Calmar Ratio Rank
OXLC Martin Ratio Rank: 3838
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

LENZ vs. OXLC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for LENZ Therapeutics Inc (LENZ) and Oxford Lane Capital Corp. (OXLC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


LENZOXLCDifference
Sharpe ratioReturn per unit of total volatility

-0.81

Sortino ratioReturn per unit of downside risk

-2.09

Omega ratioGain probability vs. loss probability

0.75

1.00

-0.25

Calmar ratioReturn relative to maximum drawdown

-0.91

-0.18

-0.74

Martin ratioReturn relative to average drawdown

-1.27

-0.34

-0.94

LENZ vs. OXLC - Sharpe Ratio Comparison

The current LENZ Sharpe Ratio is -1.01, which is lower than the OXLC Sharpe Ratio of -0.20. The chart below compares the historical Sharpe Ratios of LENZ and OXLC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

LENZ vs. OXLC - Drawdown Comparison

The maximum LENZ drawdown since its inception was -95.23%, which is greater than OXLC's maximum drawdown of -74.58%. Use the drawdown chart below to compare losses from any high point for LENZ and OXLC.


Loading charts...

Drawdown Indicators


LENZOXLCDifference

Max Drawdown

Largest peak-to-trough decline

-95.23%

-74.58%

-20.65%

Max Drawdown (1Y)

Largest decline over 1 year

-90.05%

-47.99%

-42.06%

Max Drawdown (3Y)

Largest decline over 3 years

-90.05%

-57.17%

-32.88%

Max Drawdown (5Y)

Largest decline over 5 years

-93.48%

-57.17%

-36.31%

Max Drawdown (10Y)

Largest decline over 10 years

-74.58%

Current Drawdown

Current decline from peak

-94.82%

-30.25%

-64.57%

Average Drawdown

Average peak-to-trough decline

-79.06%

-14.19%

-64.87%

Ulcer Index

Depth and duration of drawdowns from previous peaks

64.52%

24.92%

+39.60%

Volatility

LENZ vs. OXLC - Volatility Comparison

LENZ Therapeutics Inc (LENZ) has a higher volatility of 22.44% compared to Oxford Lane Capital Corp. (OXLC) at 6.14%. This indicates that LENZ's price experiences larger fluctuations and is considered to be riskier than OXLC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LENZOXLCDifference

Volatility (1M)

Calculated over the trailing 1-month period

22.44%

6.14%

+16.30%

Volatility (6M)

Calculated over the trailing 6-month period

54.70%

37.20%

+17.50%

Volatility (1Y)

Calculated over the trailing 1-year period

81.71%

43.07%

+38.64%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

75.56%

28.65%

+46.91%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

77.19%

43.31%

+33.88%

Dividends

LENZ vs. OXLC - Dividend Comparison

LENZ has not paid dividends to shareholders, while OXLC's dividend yield for the trailing twelve months is around 66.85%.


PositionTTM20252024202320222021202020192018201720162015
LENZ
LENZ Therapeutics Inc
0.00%0.00%28.54%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
OXLC
Oxford Lane Capital Corp.
66.85%35.86%20.12%18.83%17.75%10.51%22.46%19.85%16.70%17.91%22.84%24.10%

Financials

LENZ vs. OXLC - Financials Comparison

This section allows you to compare key financial metrics between LENZ Therapeutics Inc and Oxford Lane Capital Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


LENZ and OXLC have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LENZ has higher volatility (22.44%) compared to OXLC (6.14%). In terms of maximum drawdown, LENZ dropped -95.23% vs OXLC's -74.58%.

OXLC currently has the higher Sharpe Ratio (-0.20 vs -1.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LENZ and OXLC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer